AU Patent

AU2009317280B2 — Prolonged release formulations comprising an 2 -oxo- 1 -pyrrolidine derivative

Assigned to UCB SA · Expires 2014-03-06 · 12y expired

What this patent protects

The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.

USPTO Abstract

The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.

Drugs covered by this patent

Patent Metadata

Patent number
AU2009317280B2
Jurisdiction
AU
Classification
—
Expires
2014-03-06
Drug substance claim
No
Drug product claim
No
Assignee
UCB SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.